{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:27:20Z","timestamp":1789576040085,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-022-01484-z","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T14:23:00Z","timestamp":1660141380000},"page":"1157-1166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Basal Cell Adenoma and Basal Cell Adenocarcinoma: a 50-year Experience From a Single Institution"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0226-5905","authenticated-orcid":false,"given":"Miguel","family":"Rito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"1484_CR1","unstructured":"WHO Classification of Head and Neck Tumours [Internet; beta version ahead of print] [Internet]. (2022) 5th ed. Lyon (France): International Agency for Research on Cancer. https:\/\/tumourclassification.iarc.who.int\/chapters\/52. Accessed 10 July 2022"},{"key":"1484_CR2","first-page":"2471","volume":"78","author":"S Muller","year":"1996","unstructured":"Muller S, Barnes L. Basal cell adenocarcinoma of the salivary glands: report of seven cases and review of the literature. Cancer Interdiscip Int J Am Cancer Soc. 1996;78:2471\u20137.","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"key":"1484_CR3","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/lary.25713","volume":"126","author":"KY Zhan","year":"2016","unstructured":"Zhan KY, Lentsch EJ. Basal cell adenocarcinoma of the major salivary glands: a population-level study of 509 cases. Laryngoscope. 2016;126:1086\u201390.","journal-title":"Laryngoscope"},{"key":"1484_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1177\/000348949110000818","volume":"100","author":"MA Luna","year":"1991","unstructured":"Luna MA, Batsakis JG, El-Naggar AK. Basaloid monomorphic adenomas. Ann Otol Rhinol Laryngol. 1991;100:687\u201390.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"1484_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0196-0709(85)80007-7","volume":"6","author":"KT Chen","year":"1985","unstructured":"Chen KT. Carcinoma arising in monomorphic adenoma of the salivary gland. Am J Otolaryngol. 1985;6:39\u201341.","journal-title":"Am J Otolaryngol"},{"key":"1484_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1017\/S0022215100109995","volume":"103","author":"MA Luna","year":"1989","unstructured":"Luna MA, Batsakis JG, Tortoledo ME, Del Junco GW. Carcinomas ex monomorphic adenoma of salivary glands. J Laryngol Otol. 1989;103:756\u20139.","journal-title":"J Laryngol Otol"},{"key":"1484_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-015-1887-4","author":"M Rito","year":"2016","unstructured":"Rito M, Fonseca I. Carcinoma ex-pleomorphic adenoma of the salivary glands has a high risk of progression when the tumor invades more than 2.5 mm beyond the capsule of the residual pleomorphic adenoma. Virchows Arch. 2016. https:\/\/doi.org\/10.1007\/s00428-015-1887-4.","journal-title":"Virchows Arch"},{"key":"1484_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0018-6","author":"M Rito","year":"2018","unstructured":"Rito M, Mitani Y, Bell D, Mariano FV, Almalki ST, Pytynia KB, et al. Frequent and differential mutations of the CYLD gene in basal cell salivary neoplasms: linkage to tumor development and progression. Mod Pathol. 2018. https:\/\/doi.org\/10.1038\/s41379-018-0018-6.","journal-title":"Mod Pathol"},{"key":"1484_CR9","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12105-016-0730-9","volume":"10","author":"TC Wilson","year":"2016","unstructured":"Wilson TC, Ma D, Tilak A, Tesdahl B, Robinson RA. Next-generation sequencing in salivary gland basal cell adenocarcinoma and basal cell adenoma. Head Neck Pathol. 2016;10:494\u2013500.","journal-title":"Head Neck Pathol"},{"key":"1484_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12105-016-0705-x","volume":"10","author":"DV Kazakov","year":"2016","unstructured":"Kazakov DV. Brooke-Spiegler syndrome and phenotypic variants: an update. Head Neck Pathol. 2016;10:125\u201330.","journal-title":"Head Neck Pathol"},{"issue":"2","key":"1484_CR11","first-page":"128","volume":"13","author":"I Fonseca","year":"1996","unstructured":"Fonseca I, Soares J. Basal cell adenocarcinoma of minor salivary and seromucous glands of the head and neck region. Semin Diagn Pathol. 1996;13(2):128\u201337.","journal-title":"Semin Diagn Pathol"},{"key":"1484_CR12","unstructured":"Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al. (Eds.). AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer. 2017."},{"key":"1484_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.joms.2009.04.091","volume":"68","author":"L Junquera","year":"2010","unstructured":"Junquera L, Gallego L, de Vicente JC, Fresno MF. Bilateral parotid basal cell adenoma: an unusual case report and review of the literature. J Oral Maxillofac Surg. 2010;68:179\u201382.","journal-title":"J Oral Maxillofac Surg"},{"key":"1484_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bjoms.2005.08.015","volume":"44","author":"M Ethunandan","year":"2006","unstructured":"Ethunandan M, Pratt CA, Morrison A, Anand R, Macpherson DW, Wilson AW. Multiple synchronous and metachronous neoplasms of the parotid gland: the Chichester experience. Br J Oral Maxillofac Surg. 2006;44:397\u2013401.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1484_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/hed.2880120410","volume":"12","author":"D Myssiorek","year":"1990","unstructured":"Myssiorek D, Ruah CB, Hybels RL. Recurrent pleomorphic adenomas of the parotid gland. Head Neck. 1990;12:332\u20136.","journal-title":"Head Neck"},{"key":"1484_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.path.2020.09.005","volume":"14","author":"RA Robinson","year":"2021","unstructured":"Robinson RA. Basal cell adenoma and basal cell adenocarcinoma. Surg Pathol Clin. 2021;14:25\u201342.","journal-title":"Surg Pathol Clin"},{"key":"1484_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S1010-5182(05)80319-1","volume":"20","author":"S Shingaki","year":"1992","unstructured":"Shingaki S, Ohtake K, Nomura T, Nakajima T. The role of radiotherapy in the management of salivary gland carcinomas. J Cranio-Maxillofacial Surg. 1992;20:220\u20134.","journal-title":"J Cranio-Maxillofacial Surg"},{"key":"1484_CR18","first-page":"439","volume":"82","author":"T Nagao","year":"1998","unstructured":"Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, et al. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Cancer Interdiscip Int J Am Cancer Soc. 1998;82:439\u201347.","journal-title":"Cancer Interdiscip Int J Am Cancer Soc"},{"key":"1484_CR19","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/dc.23820","volume":"45","author":"AC Schmitt","year":"2017","unstructured":"Schmitt AC, Griffith CC, Cohen C, Siddiqui MT. LEF-1: diagnostic utility in distinguishing basaloid neoplasms of the salivary gland. Diagn Cytopathol. 2017;45:1078\u201383.","journal-title":"Diagn Cytopathol"},{"key":"1484_CR20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.humpath.2014.10.018","volume":"46","author":"EA Bilodeau","year":"2015","unstructured":"Bilodeau EA, Acquafondata M, Barnes EL, Seethala RR. A comparative analysis of LEF-1 in odontogenic and salivary tumors. Hum Pathol. 2015;46:255\u20139.","journal-title":"Hum Pathol"},{"key":"1484_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1600-0714.2011.01010.x","volume":"40","author":"A Kawahara","year":"2011","unstructured":"Kawahara A, Harada H, Abe H, Yamaguchi T, Taira T, Nakashima K, et al. Nuclear \u03b2-catenin expression in basal cell adenomas of salivary gland. J Oral Pathol Med. 2011;40:460\u20136.","journal-title":"J Oral Pathol Med"},{"key":"1484_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/PAS.0000000000000669","volume":"40","author":"VY Jo","year":"2016","unstructured":"Jo VY, Sholl LM, Krane JF. Distinctive patterns of CTNNB1 (\u03b2-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol. 2016;40:1143\u201350.","journal-title":"Am J Surg Pathol"},{"key":"1484_CR23","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.jfma.2017.11.011","volume":"117","author":"Y-H Lee","year":"2018","unstructured":"Lee Y-H, Huang W-C, Hsieh M-S. CTNNB1 mutations in basal cell adenoma of the salivary gland. J Formos Med Assoc. 2018;117:894\u2013901.","journal-title":"J Formos Med Assoc"},{"key":"1484_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.prp.2017.12.016","volume":"214","author":"M Sato","year":"2018","unstructured":"Sato M, Yamamoto H, Hatanaka Y, Nishijima T, Jiromaru R, Yasumatsu R, et al. Wnt\/\u03b2-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland. Pathol Pract. 2018;214:586\u201392.","journal-title":"Pathol Pract"},{"key":"1484_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-1596-8-171","volume":"8","author":"MJ Jung","year":"2013","unstructured":"Jung MJ, Roh J-L, Choi S-H, Nam SY, Kim SY, Lee S, et al. Basal cell adenocarcinoma of the salivary gland: a morphological and immunohistochemical comparison with basal cell adenoma with and without capsular invasion. Diagn Pathol. 2013;8:1\u20138.","journal-title":"Diagn Pathol"},{"key":"1484_CR26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00449","author":"JL Geiger","year":"2021","unstructured":"Geiger JL, Ismaila N, Beadle B, Caudell JJ, Chau N, Deschler D, et al. Management of salivary gland malignancy: ASCO guideline. J Clin Oncol. 2021. https:\/\/doi.org\/10.1200\/JCO.21.00449.","journal-title":"J Clin Oncol"},{"key":"1484_CR27","unstructured":"National Comprehensive Cancer Network (2021) NCCN Guidelines Head and Neck [Internet]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed 10 July 2022"},{"key":"1484_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/156800908786733504","volume":"8","author":"JP Gustin","year":"2008","unstructured":"Gustin JP, Cosgrove DP, Park BH. The PIK3CA gene as a mutated target for cancer therapy. Curr Cancer Drug Targets. 2008;8:733\u201340.","journal-title":"Curr Cancer Drug Targets"},{"key":"1484_CR29","unstructured":"FDA (2019) FDA approves alpelisib for metastatic breast cancer [Internet]. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-alpelisib-metastatic-breast-cancer. Accessed 10 July 2022"},{"key":"1484_CR30","first-page":"4243","volume":"30","author":"N Rajan","year":"2011","unstructured":"Rajan N, Elliott R, Clewes O, Mackay A, Reis-Filho JS, Burn J, et al. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours. Oncogene Nature Publishing Group. 2011;30:4243\u201360.","journal-title":"Oncogene Nature Publishing Group"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-022-01484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-022-01484-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-022-01484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T18:16:12Z","timestamp":1670436972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-022-01484-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1484"],"URL":"https:\/\/doi.org\/10.1007\/s12105-022-01484-z","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"22 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional board of Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil (Lisboa, Portugal), project number UIC\/993.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human and Animals Rights"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}